参考文献/References:
[1] Li R,Daguzan M,Vandermijnsbrugge F,et al.Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis[J].Acta Clin Belg,2014,25(2):246-250.
[2] Chighizola CB,Gerosa M,Meroni PL,et al.New tests to detect antiphospholipid antibodies:anti-domain I beta2 glycoprotein I antibodies[J].Curr Rheumatol Rep,2014,16(2):402.
[3] Rahgozar S.Revisiting beta 2 glycopmtein I,the major autoantigen in theantiphospholipid syndrome[J].Iran J Immunol,2012,9(2):73-85.
[4] Agar C,van Os GM,Morgelin M,et al.Beta 2 glycoprotein I can exist in2 conformations:implications for our understanding of the antiphospholipid syndrome[J].Blood,2010,116(8):1336-1343.
[5] de Laat B,van Berkel M,Urbanus RT,et al.Immune responses against domain I of beta 2 glycoprotein I are driven by conformational changes:domain I ofbeta 2 glycoprotein I harbors a cryptic immunogenic epitope[J].Arth Rheum,2011,63(12):3960-3968.
[6] Gharavi AE,Pierangeli SS,Espinola RG,et al.Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide causethrombosis and activation of endothelial cells in vivo[J].Arth Rheum,2002,46(2):545-552.
[7] van Os GM,Meijers JC,Agar C,et al.Induction of anti Beta 2 glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes[J].J Thromb Haemost,2011,9(12):2447-2456.
[8] Agar C,de Groot PG,Morgelin M,et al.β 2 glycoprotein I:a novel component of innate immunity[J].Blood,2011,117(25):6939-6947.
[9] Fischetti F,Durigutto P,Pellis V,et al.Thrombus formation induced byantibodies to beta 2 glycoprotein I is complement dependent and requires a priming factor[J].Blood,2005,106(7):2340-2346.
[10] Arad A,Proulle V,Furie RA,et al.β 2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model[J].Blood,2011,117(12):3453-3459.
[11] Reshetniak TM,Alekberova ZS,Aleksandrova EN.Clinico-immunological aspects of antiphospholipid syndrome[J].Vestn Ross Akad Med Nauk,2003(7):31-34.
[12] Kawaguchi R,Nunomura S,Umehara N,et al.Multiple injections of anti-mouse β2 glycoprotein 1 antibody induce FcRγ-dependent fetal growth restriction(FGR)in mice[J].Placenta,2012,33(7):540-547.
[13] Raschi E,Sroggini V,Borghi M,et al.TLR4 and annein A2 involvement inendothelial cell activation by antiphospholipid antibodies:specific silencingby small interfering RNAs[J].Arthritis Rheum,2010,10(62):135-136.
[14] Allen KL,Fonseca FV,Betapudi V,et al.A novel pathway for human endothelial cell activation by antiphospholipid/anti-Beta2 glycoprotein I antibodies[J].Blood,2012,119(3):884-893.
[15] Sorice M,Longo A,Capozzi A,et al.Anti-beta2-glycoprotein I antibodiesinduce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts[J].Arthritis and Rheumatism,2007,56(8):2687-2697.
[16] 解鸿翔,周 红,王海波,等.β2PGPI/抗β2GPI抗体复合物激活THP-1细胞内TRIF途径[J].细胞与分子免疫学杂志,2011,27(12):1280-1283.
Xie HX,Zhou H,Wang HB,et al.The activation of TRIF-dependent signa-ling pathway in THP-1 cells induced by β2GPI/anti-β2GPI antibodies complex[J].Journal of Cellular and Molecular Immunology,2011,27(12):1280-1283.
[17] Urbanus RT,Pennings MT,Derksen RH,et al.Pla-telet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ib alpha andapolipoprotein E receptor 2'[J].J Thromb Haemost,2008,6(8):1405-1412.
[18] Sikara MP,Routsias JG,Samiotaki M,et al.β2 glycoprotein I(β2 GPI)binds platelet factor 4(PF4):implications for the pathogenesis of antiphospholipid syndrome[J].Blood,2010,115(3):713-723.
[19] Meroni PL,Borghi MO,Raschi E,et al.Pathogenesis of antiphospholipidsyndrome:understanding the antibodies[J].Nat Rev Rheumatol,2011,7(6):330-339.
[20] Iverson GM,Matsuura E,Victoria EJ,et al.The orientation of β2 GPI on the plate is important for the binding of anti-beta2 GPI autoantibodies by ELISA[J].J Autoimmun,2002,18(4):289-297.
[21] Pierangeli SS,Favaloro EJ,Lakos G,et al.Standards and reference materials for the anticardiolipin and anti-beta 2 glycoprotein I assays:a report of recommendations from the APL task force at the 13th international congress onantiphospholipid antibodies[J].Clin Chim Acta,2012,413(1/2):358-360.
[22] Forastiem R,Martinuzzo M,de Larranaga G,et al.Anti-beta2-glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an invivo animal model[J].J Thrombosis Haemost,2011,9(4):859-861.
[23] Andreoli L,Nalli C,Motta M,et al.Anti-beta2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5:might it be the reason for their‘innocent' profile?[J].Ann Rheum Dis,2011,70(2):380-303.
[24] de Laat B,Pengo V,Pabinger I,et al.The association between circulating antibodies against domain I of beta2 glycoprotein I and thrombosis: an international multicenter study[J].J Thromb Haemost,2009,7(11):1767-1773.
[25] Zohoury N,Khamashta MA,Atsumi T,et al.Autoantibodies targeting domain 1 of beta 2 glycoprotein I as promising marker in the diagnosis and risk stratification of the antiphospholipid syndrome[J].Arthritis Rheum,2013,65(10):S4-S5.
[26] Ioannou Y,Giles I,Lambrianides A,et al.A novel expression system ofdomain I of human beta 2 glycoprotein I in Escherichia coli[J].BMC Biotechnol,2006(6):8.
[27] Ioannou Y,Romay-Penabad Z,Pericleous C,et al.In vivo inhibition ofantiphospholipid antibody-induced pathogenicity utilizing the antigenic targetpeptide domain I of beta2 glycoprotein I:proof of concept[J].J Thromb Haemost,2009,7(5):833-842.
[28] Ostertag MV,Liu X,Henderson V,et al.A peptide that mimics the Vth region of beta2 glycoprotein I reverses antiphospholipid-mediated thrombosis in mice[J].Lupus,2006,15(6):358-365.
[29] Kolyada A,Porter A,Beglova N,et al.Inhibition of thrombotic properties of persistent autoimmune anti-β2 GPI antibodies in the mouse model of antiphospholipid syndrome[J].Blood,2014,123(7):1090-1097.